Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance?

Høberg-Vetti H, Ognedal E, Buisson A, Vamre TBA, Ariansen S, Hoover JM, Eide GE, Houge G, Fiskerstrand T, Haukanes BI, Bjorvatn C, Knappskog PM.

Eur J Hum Genet. 2020 Mar 20. doi: 10.1038/s41431-020-0612-1. [Epub ahead of print]

PMID:
32203205
2.

Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI).

Norekvål TM, Allore HG, Bendz B, Bjorvatn C, Borregaard B, Brørs G, Deaton C, Fålun N, Hadjistavropoulos H, Hansen TB, Igland S, Larsen AI, Palm P, Pettersen TR, Rasmussen TB, Schjøtt J, Søgaard R, Valaker I, Zwisler AD, Rotevatn S; CONCARD Investigators.

BMJ Open. 2020 Feb 12;10(2):e031995. doi: 10.1136/bmjopen-2019-031995.

3.

A novel governance framework for GMO: A tiered, more flexible regulation for GMOs would help to stimulate innovation and public debate.

Bratlie S, Halvorsen K, Myskja BK, Mellegård H, Bjorvatn C, Frost P, Heiene G, Hofmann B, Holst-Jensen A, Holst-Larsen T, Malnes RS, Paus B, Sandvig B, Sjøli SI, Skarstein B, Thorseth MB, Vagstad N, Våge DI, Borge OJ.

EMBO Rep. 2019 May;20(5). pii: e47812. doi: 10.15252/embr.201947812. Epub 2019 Apr 23. No abstract available.

PMID:
31015362
4.

Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.

Høberg-Vetti H, Eide GE, Siglen E, Listøl W, Haavind MT, Hoogerbrugge N, Bjorvatn C.

Acta Oncol. 2019 Feb;58(2):175-181. doi: 10.1080/0284186X.2018.1502466. Epub 2018 Oct 18.

PMID:
30334464
5.

Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer.

Listøl W, Høberg-Vetti H, Eide GE, Bjorvatn C.

Hered Cancer Clin Pract. 2017 Jan 11;15:2. doi: 10.1186/s13053-016-0062-5. eCollection 2017.

6.

Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.

Augestad MT, Høberg-Vetti H, Bjorvatn C, Sekse RJ.

J Genet Couns. 2017 Feb;26(1):182-189. doi: 10.1007/s10897-016-9996-z. Epub 2016 Jul 28.

7.

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.

Høberg-Vetti H, Bjorvatn C, Fiane BE, Aas T, Woie K, Espelid H, Rusken T, Eikesdal HP, Listøl W, Haavind MT, Knappskog PM, Haukanes BI, Steen VM, Hoogerbrugge N.

Eur J Hum Genet. 2016 Jun;24(6):881-8. doi: 10.1038/ejhg.2015.196. Epub 2015 Sep 9.

8.

What information do cancer genetic counselees prioritize?

Hayat Roshanai A, Lampic C, Ingvoldstad C, Askmalm MS, Bjorvatn C, Rosenquist R, Nordin K.

J Genet Couns. 2012 Aug;21(4):510-26. doi: 10.1007/s10897-011-9409-2. Epub 2011 Oct 13.

PMID:
21993709
9.

Is genetic counseling a stressful event?

Nordin K, Roshanai A, Bjorvatn C, Wollf K, Mikkelsen EM, Bjelland I, Kvale G.

Acta Oncol. 2011 Oct;50(7):1089-97. doi: 10.3109/0284186X.2011.604343. Epub 2011 Aug 24.

10.

Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up.

Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Øyen N.

J Genet Couns. 2012 Feb;21(1):72-84. doi: 10.1007/s10897-011-9393-6. Epub 2011 Jul 20.

PMID:
21773878
11.

Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Hamang A, Eide GE, Nordin K, Rokne B, Bjorvatn C, Øyen N.

BMC Med Genet. 2010 Feb 17;11:27. doi: 10.1186/1471-2350-11-27.

12.

[Genetic counseling in congenital long QT syndrome].

Hamang A, Solberg B, Bjorvatn C, Greve G, Øyen N.

Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1226-9. doi: 10.4045/tidsskr.09.32621. Review. Norwegian.

13.

Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer.

Bjorvatn C, Eide GE, Hanestad BR, Hamang A, Havik OE.

Support Care Cancer. 2009 Nov;17(11):1371-81. doi: 10.1007/s00520-009-0594-6. Epub 2009 Feb 18.

PMID:
19224252
14.

Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death.

Andersen J, Øyen N, Bjorvatn C, Gjengedal E.

J Genet Couns. 2008 Oct;17(5):489-98. doi: 10.1007/s10897-008-9167-y. Epub 2008 Aug 22.

PMID:
18719982
15.

Anxiety and depression among subjects attending genetic counseling for hereditary cancer.

Bjorvatn C, Eide GE, Hanestad BR, Havik OE.

Patient Educ Couns. 2008 May;71(2):234-43. doi: 10.1016/j.pec.2008.01.008. Epub 2008 Mar 4.

PMID:
18295433
16.
17.

Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer.

Bjorvatn C, Eide GE, Hanestad BR, Øyen N, Havik OE, Carlsson A, Berglund G.

J Genet Couns. 2007 Apr;16(2):211-22.

PMID:
17279329
18.

Psychosocial factors associated with quality of life among individuals attending genetic counseling for hereditary cancer.

Carlsson AH, Bjorvatn C, Engebretsen LF, Berglund G, Natvig GK.

J Genet Couns. 2004 Oct;13(5):425-45.

PMID:
15604640

Supplemental Content

Loading ...
Support Center